2 Magnificent Growth Stocks With Room to Run
The Motley Fool
MARCH 27, 2024
Prime Medicine (NASDAQ: PRME) and Tilray Brands (NASDAQ: TLRY) are two small-cap growth stocks that have struggled in the current high-interest-rate environment but now appear significantly undervalued from a long-term perspective. Small-cap growth stocks have markedly underperformed the S&P 500 over the past three years.
Let's personalize your content